EarningsQ4 2023 Earnings Report

ANI Pharmaceuticals (BSFA) Q4 2023 Earnings Report

0 Followers

CH:BSFA Q4 2023 EPS Results

Actual EPSCHF0.83

Consensus EPSCHF0.71

Beat/MissBeat by +CHF0.12

One Year Ago EPSCHF0.63

Actual RevenueCHF109.21M

Expected RevenueCHF103.64M

Beat/MissBeat by +CHF5.57M

YoY Revenue Growth+39.71%

QuarterQ4 2023

Date02/29/2024

TimeBefore Open

Conference CallThursday, February 29, 2024

CH:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

CH:BSFA Q4 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.81 / -	1.692	―
Aug 07, 2026	2026 (Q2)	1.69 / 1.83	1.493	22.78% (+0.34)
May 08, 2026	2026 (Q1)	1.08 / 1.70	1.41	20.59% (+0.29)
Mar 03, 2026	2025 (Q4)	1.65 / 1.93	1.352	42.94% (+0.58)
Nov 10, 2025	2025 (Q3)	1.47 / 1.69	1.112	52.24% (+0.58)
Aug 08, 2025	2025 (Q2)	1.17 / 1.49	0.846	76.47% (+0.65)
May 09, 2025	2025 (Q1)	1.15 / 1.41	1.004	40.50% (+0.41)
Feb 28, 2025	2024 (Q4)	1.19 / 1.35	0.83	63.00% (+0.52)
Nov 08, 2024	2024 (Q3)	0.90 / 1.11	1.054	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.79 / 0.85	1.062	-20.31% (-0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed